Literature DB >> 18165276

Consensus characterization of 16 FMR1 reference materials: a consortium study.

Jean Amos Wilson1, Victoria M Pratt, Amit Phansalkar, Kasinathan Muralidharan, W Edward Highsmith, Jeanne C Beck, Scott Bridgeman, Ebony M Courtney, Lidia Epp, Andrea Ferreira-Gonzalez, Nick L Hjelm, Leonard M Holtegaard, Mohamed A Jama, John P Jakupciak, Monique A Johnson, Paul Labrousse, Elaine Lyon, Thomas W Prior, C Sue Richards, Kristy L Richie, Benjamin B Roa, Elizabeth M Rohlfs, Tina Sellers, Stephanie L Sherman, Karen A Siegrist, Lawrence M Silverman, Joanna Wiszniewska, Lisa V Kalman.   

Abstract

Fragile X syndrome, which is caused by expansion of a (CGG)(n) repeat in the FMR1 gene, occurs in approximately 1:3500 males and causes mental retardation/behavioral problems. Smaller (CGG)(n) repeat expansions in FMR1, premutations, are associated with premature ovarian failure and fragile X-associated tremor/ataxia syndrome. An FMR1-sizing assay is technically challenging because of high GC content of the (CGG)(n) repeat, the size limitations of conventional PCR, and a lack of reference materials available for test development/validation and routine quality control. The Centers for Disease Control and Prevention and the Association for Molecular Pathology, together with the genetic testing community, have addressed the need for characterized fragile X mutation reference materials by developing characterized DNA samples from 16 cell lines with repeat lengths representing important phenotypic classes and diagnostic cutoffs. The alleles in these materials were characterized by consensus analysis in nine clinical laboratories. The information generated from this study is available on the Centers for Disease Control and Prevention and Coriell Cell Repositories websites. DNA purified from these cell lines is available to the genetics community through the Coriell Cell Repositories. The public availability of these reference materials should help support accurate clinical fragile X syndrome testing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165276      PMCID: PMC2175538          DOI: 10.2353/jmoldx.2008.070105

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  20 in total

1.  Standardization of PCR amplification for fragile X trinucleotide repeat measurements.

Authors:  C D O'Connell; D H Atha; J P Jakupciak; J A Amos; K l Richie
Journal:  Clin Genet       Date:  2002-01       Impact factor: 4.438

2.  Detection of FMR1 trinucleotide repeat expansion mutations using Southern blot and PCR methodologies.

Authors:  Jack Tarleton
Journal:  Methods Mol Biol       Date:  2003

3.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

Authors:  R J Hagerman; M Leehey; W Heinrichs; F Tassone; R Wilson; J Hills; J Grigsby; B Gage; P J Hagerman
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

4.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

5.  Mouse tissue culture models of unstable triplet repeats: in vitro selection for larger alleles, mutational expansion bias and tissue specificity, but no association with cell division rates.

Authors:  M Gomes-Pereira; M T Fortune; D G Monckton
Journal:  Hum Mol Genet       Date:  2001-04-01       Impact factor: 6.150

Review 6.  Premature ovarian failure in the fragile X syndrome.

Authors:  S L Sherman
Journal:  Am J Med Genet       Date:  2000

7.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

Review 8.  The fragile X premutation: into the phenotypic fold.

Authors:  Randi J Hagerman; Paul J Hagerman
Journal:  Curr Opin Genet Dev       Date:  2002-06       Impact factor: 5.578

9.  Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase.

Authors:  S S Chong; E E Eichler; D L Nelson; M R Hughes
Journal:  Am J Med Genet       Date:  1994-07-15

10.  Detection of full fragile X mutation.

Authors:  R G Pergolizzi; S H Erster; P Goonewardena; W T Brown
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

View more
  16 in total

1.  Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.

Authors:  Shannon D Barker; Sherri Bale; Jessica Booker; Arlene Buller; Soma Das; Kenneth Friedman; Andrew K Godwin; Wayne W Grody; Edward Highsmith; Jeffery A Kant; Elaine Lyon; Rong Mao; Kristin G Monaghan; Deborah A Payne; Victoria M Pratt; Iris Schrijver; Antony E Shrimpton; Elaine Spector; Milhan Telatar; Lorraine Toji; Karen Weck; Barbara Zehnbauer; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-09-18       Impact factor: 5.568

2.  A novel assay for evaluating fragile X locus repeats.

Authors:  Karl Adler; J Kent Moore; Galina Filippov; Shaoping Wu; Jon Carmichael; Mack Schermer
Journal:  J Mol Diagn       Date:  2011-07-26       Impact factor: 5.568

Review 3.  Reference standards for next-generation sequencing.

Authors:  Simon A Hardwick; Ira W Deveson; Tim R Mercer
Journal:  Nat Rev Genet       Date:  2017-06-19       Impact factor: 53.242

4.  Bridging the gap: moving predictive and prognostic assays from research to clinical use.

Authors:  P Michael Williams; Tracy G Lively; J Milburn Jessup; Barbara A Conley
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

5.  A simple, high-throughput assay for Fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis.

Authors:  Elaine Lyon; Thomas Laver; Ping Yu; Mohamed Jama; Keith Young; Michael Zoccoli; Natalia Marlowe
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

6.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

7.  Preparation and validation of the first WHO international genetic reference panel for Fragile X syndrome.

Authors:  Malcolm Hawkins; Jennifer Boyle; Kathleen E Wright; Rob Elles; Simon C Ramsden; Anna O'Grady; Michael Sweeney; David E Barton; Trent Burgess; Melanie Moore; Chris Burns; Glyn Stacey; Elaine Gray; Paul Metcalfe; J Ross Hawkins
Journal:  Eur J Hum Genet       Date:  2010-08-25       Impact factor: 4.246

8.  An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis.

Authors:  Liangjing Chen; Andrew Hadd; Sachin Sah; Stela Filipovic-Sadic; Julie Krosting; Edward Sekinger; Ruiqin Pan; Paul J Hagerman; Timothy T Stenzel; Flora Tassone; Gary J Latham
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

9.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Authors:  Stela Filipovic-Sadic; Sachin Sah; Liangjing Chen; Julie Krosting; Edward Sekinger; Wenting Zhang; Paul J Hagerman; Timothy T Stenzel; Andrew G Hadd; Gary J Latham; Flora Tassone
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

10.  High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.

Authors:  Liangjing Chen; Andrew Hadd; Sachin Sah; Jeffrey F Houghton; Stela Filipovic-Sadic; Wenting Zhang; Paul J Hagerman; Flora Tassone; Gary J Latham
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.